Health News

Who Is Getting Highly Effective MS Treatments? And When?

 2 months ago       52 Views

On the surface, the phrase “highly effective treatments” (HET) sounds pretty straightforward. But if you’ve been diagnosed with relapsing-remitting multiple sclerosis (RRMS), the phrase comes with a bit of a catch.

That’s because the term (sometimes spelled out as “higher-efficacy therapies”) refers to a specific group of disease-modifying drugs: the monoclonal antibodies Lemtrada (alemtuzumab), Tysabri (natalizumab), Ocrevus (ocrelizumab), and Rituxan (rituximab). (Rituxan is sometimes used off-label to treat MS.)

And while studies have indeed shown these drugs to be effective at reducing relapses in RRMS, they’ve also been associated with significant side effects, including increased risk for serious infusion reactions, infection, stroke, and liver damage, depending on the particular drug.

Author: @DailyCupofYoga


Join the community!

You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.